Literature DB >> 24759709

CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.

Laurent Dortet1, Laurent Poirel2, Caroline Errera1, Patrice Nordmann3.   

Abstract

Multidrug-resistant Acinetobacter baumannii isolates, particularly those that produce carbapenemases, are increasingly reported worldwide. The biochemically based Carba NP test, extensively validated for the detection of carbapenemase producers among Enterobacteriaceae and Pseudomonas spp., has been modified to detect carbapenemase production in Acinetobacter spp. A collection of 151 carbapenemase-producing and 69 non-carbapenemase-producing Acinetobacter spp. were tested using the Carba NP test and a modified Carba NP protocol (the CarbAcineto NP test) in this study. The CarbAcineto NP test requires modified lysis conditions and an increased bacterial inoculum compared to those of the original Carba NP test. The Carba NP test detects metallo-β-lactamase producers but failed to detect the production of other carbapenemase types among Acinetobacter spp. In contrast, the newly designed CarbAcineto NP test, which is rapid and reproducible, detects all types of carbapenemases with a sensitivity of 94.7% and a specificity of 100%. This cost-effective technique offers a reliable and affordable technique for identifying carbapenemase production in Acinetobacter spp., which is a marker of multidrug resistance in those species. Its use will facilitate the recognition of these carbapenemases and prevent their spread.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759709      PMCID: PMC4097681          DOI: 10.1128/JCM.00594-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

Review 2.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test.

Authors:  Laurent Dortet; Ludivine Bréchard; Laurent Poirel; Patrice Nordmann
Journal:  J Med Microbiol       Date:  2014-03-03       Impact factor: 2.472

4.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

6.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

7.  Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory.

Authors:  Clare Franklin; Lisa Liolios; Anton Y Peleg
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

8.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

9.  GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.

Authors:  Carole Moubareck; Sylvie Brémont; Marie-Christine Conroy; Patrice Courvalin; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

10.  Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii.

Authors:  B A Evans; S Brown; A Hamouda; J Findlay; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2007-09-11       Impact factor: 8.067

View more
  51 in total

1.  Simplified Protocol for Carba NP Test for Enhanced Detection of Carbapenemase Producers Directly from Bacterial Cultures.

Authors:  Fernando Pasteran; Nathalie Tijet; Roberto G Melano; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2015-09-30       Impact factor: 5.948

2.  Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla(KPC), bla(NDM) and/or bla(VIM), and bla(OXA)-48 from Perirectal Swabs.

Authors:  Anna F Lau; Gary A Fahle; Margaret A Kemp; Agatha N Jassem; John P Dekker; Karen M Frank
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

Review 3.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

4.  A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469.

Authors:  Ana M Gonzalez-Villoria; Elsa Tamayo-Legorreta; Ulises Garza-Ramos; Humberto Barrios; Alejandro Sanchez-Pérez; Nadia Rodríguez-Medina; Naville Uribe-Aviña; Miguel A Cevallos; Jesus Silva-Sanchez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Sandrine Bernabeu; Lélia Escaut; Daniel Vittecoq; Delphine Girlich; Dilek Imanci; Nicolas Fortineau; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.

Authors:  Agila Kumari Pragasam; Rani Diana Sahni; Shalini Anandan; Archa Sharma; Radha Gopi; Noorjahan Hadibasha; Priya Gunasekaran; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 7.  Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.

Authors:  Thomas J Gniadek; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

8.  Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli.

Authors:  Patricia J Simner; Belita N A Opene; Krizia K Chambers; Matthew E Naumann; Karen C Carroll; Pranita D Tamma
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

9.  Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers.

Authors:  Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

Review 10.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.